A 19-year-old man was diagnosed with HIV 6 weeks prior. His initial laboratory studies showed an HIV RNA level of 87,622 copies/mL, a CD4 count 722 cells/mm³, positive hepatitis B surface antibody (HBsAb), negative hepatitis B core antibody (HBcAb), and negative hepatitis B surface antigen (HBsAg). There was a 5-week delay in establishing his initial follow-up appointment to start antiretroviral therapy. Results from an HIV drug resistance genotype test are now available and show no resistance mutations. He has never taken HIV preexposure prophylaxis (PrEP).